Carregant...

Pyruvate minimizes rtPA toxicity from in vitro oxygen-glucose deprivation and reoxygenation

Clinical application of recombinant tissue plasminogen activator (rtPA) for stroke is limited by hemorrhagic transformation, which narrows rtPA’s therapeutic window. In addition, mounting evidence indicates that rtPA is potentially neurotoxic if it traverses a compromised blood brain barrier. Here,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ryou, Myoung-Gwi, Choudhury, Gourav Roy, Winters, Ali, Xie, Luokun, Mallet, Robert T., Yang, Shao-Hua
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007160/
https://ncbi.nlm.nih.gov/pubmed/23891792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2013.07.029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!